{
  "url": "https://finance.yahoo.com/news/hosen-groups-catalist-5ev-solid-004647970.html",
  "authorsByline": "Simply Wall St",
  "articleId": "dfff78ffd4ee49f390c8ac4ab9de8ec7",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/simply_wall_st__316/83f76d21c91eb2ec8cc8f3adfb3843d7",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-15T00:46:47+00:00",
  "addDate": "2025-08-15T01:07:45.025841+00:00",
  "refreshDate": "2025-08-15T01:07:45.025843+00:00",
  "score": 1.0,
  "title": "Hosen Group's (Catalist:5EV) Solid Earnings May Rest On Weak Foundations",
  "description": "Catalist:5EV 1 Year Share Price vs Fair Value Explore Hosen Group's Fair Values from the Community and select yours...",
  "content": "Explore Hosen Group's Fair Values from the Community and select yours\n\n\n\nHosen Group Ltd. (Catalist:5EV) just released a solid earnings report, and the stock displayed some strength. However, we think that shareholders should be cautious as we found some worrying factors underlying the profit.\n\nAI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.\n\nFor anyone who wants to understand Hosen Group's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from S$314k worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. If Hosen Group doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.\n\nNote: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hosen Group.\n\nOur Take On Hosen Group's Profit Performance\n\nWe'd posit that Hosen Group's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Because of this, we think that it may be that Hosen Group's statutory profits are better than its underlying earnings power. The silver lining is that its EPS growth over the last year has been really wonderful, even if it's not a perfect measure. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. In terms of investment risks, we've identified 2 warning signs with Hosen Group, and understanding these bad boys should be part of your investment process.\n\nThis note has only looked at a single factor that sheds light on the nature of Hosen Group's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.\n\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.\n\n\n\nThis article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.",
  "medium": "Article",
  "links": [
    "https://simplywall.st/stock/catalist/5ev?blueprint=3991097&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-stocks-page",
    "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D/health?blueprint=3991097&utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo",
    "https://simplywall.st/discover/investing-ideas/16053/high-return-on-equity-low-debt?blueprint=3991097&utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo",
    "https://simplywall.st/discover/investing-ideas/434426/us-transformative-artificial-intelligence-ai-healthcare-stocks/global?blueprint=3991097&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=ai-healthcare",
    "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D?blueprint=3991097&utm_medium=finance_user&utm_campaign=intro&utm_source=yahoo",
    "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D/past?blueprint=3991097&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
    "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership?blueprint=3991097&utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo",
    "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D?blueprint=3991097&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo"
  ],
  "labels": [],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "Hosen Group",
      "weight": 0.10489401
    },
    {
      "name": "Hosen Group Ltd.",
      "weight": 0.0998902
    },
    {
      "name": "statutory profit",
      "weight": 0.08871174
    },
    {
      "name": "higher profit",
      "weight": 0.08397103
    },
    {
      "name": "Hosen Groups statutory profits",
      "weight": 0.07435765
    },
    {
      "name": "stocks",
      "weight": 0.073258005
    },
    {
      "name": "Hosen Groups statutory earnings",
      "weight": 0.07259846
    },
    {
      "name": "listed companies",
      "weight": 0.07016199
    },
    {
      "name": "significant unusual items",
      "weight": 0.06921851
    },
    {
      "name": "unusual items",
      "weight": 0.0692086
    }
  ],
  "topics": [
    {
      "name": "Markets"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.984375
    },
    {
      "name": "/News/Business News/Company News",
      "score": 0.98095703125
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.97412109375
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.703125
    }
  ],
  "sentiment": {
    "positive": 0.19996469,
    "negative": 0.39835742,
    "neutral": 0.40167788
  },
  "summary": "Hosen Group Ltd. (Catalist:5EV) recently reported a solid earnings report, but investors should be cautious due to worrying factors underlying the profit. The company's statutory earnings were gained from S$314k worth of unusual items in the last 12 months, which may cause its profit to drop over the current year. However, this is not a clean read on ongoing productivity due to the large unusual item. The article suggests that Hosen Group's statutory profits may be better than its underlying earnings power, but its growth over the last year has been wonderful. It also highlights that investors should check balance sheet strength.",
  "shortSummary": "Hosen Group's solid earnings report may underwhelm investors due to unusual items, which may also obscure underlying earnings, and require investor caution.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": false,
  "reprintGroupId": "5b769d50d4f24eb4ab0b21b3c2b17047",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://simplywall.st/stock/catalist/5ev?blueprint=3991097&utm_medium=finance_user&utm_campaign=narratives-news-header&utm_source=yahoo&utm_content=narrative-header-stocks-page",
      "text": "Hosen Group Ltd., an investment holding company, engages in the development, trading, and distribution of canned seafood products, canned fruits and vegetables, canned meat products, and chocolate products in Singapore, Malaysia, China, and internationally. It operates through two segments, House Brands and Non-House Brands. The company offers a range of canned food, such as freshly picked and packed fruits and vegetables, condiments, and beverages under the Hosen brand name; canned seafood, such as braised abalone and various types of shellfish under the Fortune brand name; meats and breakfast spreads under the Highway brand; Olive Oil with White Truffle Dressing, Balsamic Vinegar of Modena, Red Grape Vinegar, and White Grape Vinegar under the LaDiva brand; non-alcoholic fizzy beverages under the Royal Select brand; and chocolate products with contents packed in bottle, pouch and tin while Cocoa Grande brand carries semi-finished and finished industrial chocolate products under the Sincero and Calbuco brands. It also engages in the importation, distribution, wholesale, and retail of household consumable goods; and trading of frozen and dried seafood related products. Hosen Group Ltd. was founded in 1970 and is headquartered in Singapore.\nSingaporean Market Performance\n7D7 Days: 1.0%\n3M3 Months: 11.1%\n1Y1 Year: 27.5%\nYTDYear to Date: 13.6%\nOver the last 7 days, the market has remained flat, although notably the Utilities sector declined by 14%. Meanwhile, the market is actually up 27% over the past year. Earnings are forecast to grow by 5.9% annually. Market details \u203a\nThis week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond."
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/10228/fast-growing-stocks-with-high-insider-ownership?blueprint=3991097&utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo",
      "text": "Results\n72\nCompanies with strong growth potential, backed by optimistic outlooks both from analysts and management.\n72 companies\nKebNi\nMarket Cap: SEK 608.7m\nDevelops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.\nKEBNI B\nSEK 2.25\n7D\n5.4%\n1Y\n50.5%\nBonesupport Holding\nMarket Cap: SEK 18.7b\nAn orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.\nBONEX\nSEK 284.60\n7D\n-9.9%\n1Y\n0.07%\nCTT Systems\nMarket Cap: SEK 2.7b\nProvides humidity control systems for aircraft in Sweden, Denmark, France, the United States, and internationally.\nCTT\nSEK 215.00\n7D\n-1.4%\n1Y\n-23.8%\nXbrane Biopharma\nMarket Cap: SEK 449.2m\nA biotechnology company, engages in the development, manufacture, and sale of biosimilars.\nXBRANE\nSEK 0.29\n7D\n1.2%\n1Y\n82.3%\nInCoax Networks\nMarket Cap: SEK 163.4m\nInCoax Networks AB (publ) re-purposes existing property coaxial networks in fiber and fixed wireless access extension deployments for communication service providers in the European Union, North America, and internationally.\nINCOAX\nSEK 1.25\n7D\n2.5%\n1Y\n-42.9%\nGuard Therapeutics International\nMarket Cap: SEK 461.8m\nA pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.\nGUARD\nSEK 22.90\n7D\n-0.4%\n1Y\n-19.4%\nPlejd\nMarket Cap: SEK 7.5b\nA technology company, develops products and services for smart lighting control in Sweden, Norway, Finland, the Netherlands, Germany, and internationally.\nPLEJD\nSEK 668.00\n7D\n1.2%\n1Y\nn/a\nC-Rad\nMarket Cap: SEK 1.1b\nDevelops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific.\nCRAD B\nSEK 33.55\n7D\n-1.9%\n1Y\n-22.4%\nWaystream Holding\nMarket Cap: SEK 327.6m\nProvides routers and switches that are used in the fiber markets and peripherals in Sweden.\nWAYS\nSEK 40.60\n7D\n3.8%\n1Y\n76.9%\nYubico\nMarket Cap: SEK 11.6b\nProvides authentication solutions for use in computers, networks, and online services.\nYUBICO\nSEK 134.60\n7D\n-0.9%\n1Y\n-55.2%\nCinis Fertilizer\nMarket Cap: SEK 190.6m\nA green tech company, produces and sells mineral fertilizers by recycling industrial waste products in Sweden.\nCINIS\nSEK 0.83\n7D\n-4.1%\n1Y\n-96.4%\nGruvaktiebolaget Viscaria\nMarket Cap: SEK 1.6b\nEngages in the exploration and evaluation of mineral resources in Sweden.\nVISC\nSEK 15.20\n7D\n-6.9%\n1Y\n-24.2%\nMentice\nMarket Cap: SEK 356.7m\nDevelops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology.\nMNTC\nSEK 13.95\n7D\n1.8%\n1Y\n-52.2%\nAAC Clyde Space\nMarket Cap: SEK 701.5m\nProvides small satellite technologies and services in Sweden, the United Kingdom, rest of Europe, the United States, Asia, and internationally.\nAAC\nSEK 107.80\n7D\n14.1%\n1Y\n209.8%\nVolati\nMarket Cap: SEK 8.3b\nA private equity firm specializing in growth capital, buyouts, add on acquisitions in mature and middle market companies.\nVOLO\nSEK 105.00\n7D\n-1.5%\n1Y\n-6.3%\nMilDef Group\nMarket Cap: SEK 7.3b\nDevelops, manufactures, and sells rugged IT solutions in Sweden, Norway, Finland, Denmark, the United Kingdom, Germany, Switzerland, the United States, Australia, and internationally.\nMILDEF\nSEK 155.00\n7D\n-6.9%\n1Y\n95.7%\nGentoo Media\nMarket Cap: SEK 1.4b\nAn iGaming technology company, together with its subsidiaries, provides solutions, products, and services to iGaming operators in Nordic countries, other European countries, and internationally.\nG2M\nSEK 10.70\n7D\n-2.7%\n1Y\n-63.4%\nEQT\nMarket Cap: SEK 401.3b\nA global private equity & venture capital firm specializing in private capital and real asset segments.\nEQT\nSEK 341.40\n7D\n1.3%\n1Y\n4.9%\nKlaria Pharma Holding AB (publ.)\nMarket Cap: SEK 114.9m\nA pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.\nKLAR\nSEK 0.47\n7D\n-8.4%\n1Y\n-10.2%\nGenovis AB (publ.)\nMarket Cap: SEK 1.7b\nDevelops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.\nGENO\nSEK 25.20\n7D\n-5.3%\n1Y\n-13.6%\nTruecaller\nMarket Cap: SEK 16.3b\nDevelops and publishes mobile caller ID applications for individuals and business in India, the Middle East, Africa, and internationally.\nTRUE B\nSEK 47.38\n7D\n-1.2%\n1Y\n35.4%\nDevyser Diagnostics\nMarket Cap: SEK 2.5b\nEngages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.\nDVYSR\nSEK 149.60\n7D\n-0.8%\n1Y\n39.2%\nMidsummer\nMarket Cap: SEK 742.2m\nDevelops, manufactures, and supplies equipment to produce flexible thin-film solar cells in Sweden, Hong Kong, Portugal, the United States, Rest of European Union, and internationally.\nMIDS\nSEK 2.20\n7D\n-19.0%\n1Y\n78.9%\nStorytel\nMarket Cap: SEK 6.5b\nProvides audiobooks and e-books streaming services.\nSTORY B\nSEK 84.40\n7D\n-0.2%\n1Y\n51.4%\nSenzime\nMarket Cap: SEK 1.0b\nA medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States.\nSEZI\nSEK 6.63\n7D\n-1.6%\n1Y\n-25.4%\nMedhelp Care Aktiebolag\nMarket Cap: SEK 205.4m\nA software-as-a-service company, operates a health platform for data-driven corporate health and supports in Sweden and Denmark.\nMEDHLP\nSEK 6.75\n7D\n0%\n1Y\n126.5%\nDiamyd Medical\nMarket Cap: SEK 1.5b\nDevelops precision medicine therapies for the treatment of autoimmune diabetes.\nDMYD B\nSEK 11.06\n7D\n0%\n1Y\n-40.1%\nMedicover\nMarket Cap: SEK 41.4b\nProvides healthcare and diagnostic services in Poland, Sweden, and internationally.\nMCOV B\nSEK 274.00\n7D\n2.2%\n1Y\n51.5%\nEgetis Therapeutics\nMarket Cap: SEK 2.0b\nA pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.\nEGTX\nSEK 5.51\n7D\n-4.0%\n1Y\n-1.6%\nQliro\nMarket Cap: SEK 641.9m\nOperates as a fintech company.\nQLIRO\nSEK 22.70\n7D\n-5.0%\n1Y\n-19.1%\nGomSpace Group\nMarket Cap: SEK 1.7b\nThrough its subsidiaries, manufactures and sells nanosatellites and components, and turnkey solutions for satellites in Denmark, Sweden, France, rest of Europe, the United States, Asia, and internationally.\nGOMX\nSEK 12.06\n7D\n3.6%\n1Y\n138.8%\nSmart Eye\nMarket Cap: SEK 2.3b\nDevelops human insight artificial intelligence (AI) technology solutions that understand, support, and predict human behavior in the Nordics countries, the rest of Europe, North America, Asia, and internationally.\nSEYE\nSEK 61.00\n7D\n-6.4%\n1Y\n-44.5%\nTeneo AI\nMarket Cap: SEK 300.8m\nProvides Al-powered and automated d voice phone calls conversations solutions through its Teneo platform in Europe, the United States, and internationally.\nTENEO\nSEK 0.61\n7D\n-5.4%\n1Y\n15.1%\nMendus\nMarket Cap: SEK 412.5m\nA biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.\nIMMU\nSEK 7.92\n7D\n-4.2%\n1Y\n-0.4%\nRaySearch Laboratories\nMarket Cap: SEK 9.4b\nA medical technology company, provides software solutions for cancer treatment worldwide.\nRAY B\nSEK 275.00\n7D\n-9.7%\n1Y\n101.6%\nLime Technologies\nMarket Cap: SEK 4.4b\nProvides software as a service (SaaS) based customer relationship management (CRM) solutions in the Nordic region.\nLIME\nSEK 329.50\n7D\n-11.8%\n1Y\n-2.7%"
    },
    {
      "url": "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D?blueprint=3991097&utm_medium=finance_user&utm_campaign=conclusion&utm_source=yahoo",
      "text": "Hosen Group (5EV) Stock Overview\nAn investment holding company, engages in the development, trading, and distribution of canned seafood products, canned fruits and vegetables, canned meat products, and chocolate products in Singapore, Malaysia, China, and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 3/6 |\n| Future Growth | 0/6 |\n| Past Performance | 5/6 |\n| Financial Health | 5/6 |\n| Dividends | 3/6 |\n5EV Community Fair Values\nSee what others think this stock is worth. Follow their fair value or set your own to get alerts.\nHosen Group Ltd. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | S$0.05 |\n| 52 Week High | S$0.053 |\n| 52 Week Low | S$0.036 |\n| Beta | 0.0014 |\n| 1 Month Change | 11.11% |\n| 3 Month Change | 4.17% |\n| 1 Year Change | 38.89% |\n| 3 Year Change | -5.66% |\n| 5 Year Change | 47.06% |\n| Change since IPO | -73.68% |\nRecent News & Updates\nRecent updates\nShareholder Returns\n| 5EV | SG Consumer Retailing | SG Market | |\n|---|---|---|---|\n| 7D | 4.2% | 0.5% | 1.0% |\n| 1Y | 38.9% | 33.9% | 27.5% |\nReturn vs Industry: 5EV exceeded the SG Consumer Retailing industry which returned 33.9% over the past year.\nReturn vs Market: 5EV exceeded the SG Market which returned 27.5% over the past year.\nPrice Volatility\n| 5EV volatility | |\n|---|---|\n| 5EV Average Weekly Movement | n/a |\n| Consumer Retailing Industry Average Movement | 4.2% |\n| Market Average Movement | 5.3% |\n| 10% most volatile stocks in SG Market | 16.7% |\n| 10% least volatile stocks in SG Market | 2.5% |\nStable Share Price: Data is not available.\nVolatility Over Time: Insufficient data to determine 5EV's volatility change over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1970 | n/a | Daniel Lim | www.hosengroup.com |\nHosen Group Ltd., an investment holding company, engages in the development, trading, and distribution of canned seafood products, canned fruits and vegetables, canned meat products, and chocolate products in Singapore, Malaysia, China, and internationally. It operates through two segments, House Brands and Non-House Brands. The company offers a range of canned food, such as freshly picked and packed fruits and vegetables, condiments, and beverages under the Hosen brand name; canned seafood, such as braised abalone and various types of shellfish under the Fortune brand name; meats and breakfast spreads under the Highway brand; Olive Oil with White Truffle Dressing, Balsamic Vinegar of Modena, Red Grape Vinegar, and White Grape Vinegar under the LaDiva brand; non-alcoholic fizzy beverages under the Royal Select brand; and chocolate products with contents packed in bottle, pouch and tin while Cocoa Grande brand carries semi-finished and finished industrial chocolate products under the Sincero and Calbuco brands.\nHosen Group Ltd. Fundamentals Summary\n| 5EV fundamental statistics | |\n|---|---|\n| Market cap | S$16.25m |\n| Earnings (TTM) | S$2.55m |\n| Revenue (TTM) | S$70.69m |\nIs 5EV overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| 5EV income statement (TTM) | |\n|---|---|\n| Revenue | S$70.69m |\n| Cost of Revenue | S$53.96m |\n| Gross Profit | S$16.73m |\n| Other Expenses | S$14.18m |\n| Earnings | S$2.55m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.0078 |\n| Gross Margin | 23.67% |\n| Net Profit Margin | 3.60% |\n| Debt/Equity Ratio | 19.3% |\nHow did 5EV perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/14 20:12 |\n| End of Day Share Price | 2025/08/14 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nHosen Group Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/434426/us-transformative-artificial-intelligence-ai-healthcare-stocks/global?blueprint=3991097&utm_medium=finance_user&utm_campaign=investing-ideas&utm_source=yahoo&utm_content=ai-healthcare",
      "text": "Results\n27\nArtificial intelligence (AI) is set to transform healthcare by enhancing diagnostics, personalizing medicine, boosting operational efficiency, expanding remote care, and accelerating research. AI outperforms humans in detecting diseases like cancer from scans, tailors treatments using genetic and lifestyle data, and streamlines hospital workflows with tools like predictive analytics and automated transcription. It powers telemedicine, monitors chronic conditions in real-time, and speeds up drug discovery by analyzing vast datasets for insights into complex diseases. Despite challenges like data privacy, bias, and integration costs, AI\u2019s ability to improve accuracy, access, and affordability could save billions and extend lives, marking a seismic shift in healthcare delivery and outcomes.\n27 companies\nCaris Life Sciences\nMarket Cap: US$9.6b\nAn artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.\nCAI\nUS$36.99\n7D\n29.4%\n1Y\nn/a\nRakovina Therapeutics\nMarket Cap: US$11.6m\nA biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.\nRKVT.F\nUS$0.41\n7D\n11.4%\n1Y\nn/a\nCosmo Pharmaceuticals\nMarket Cap: US$897.4m\nFocuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.\nCMOP.F\nUS$75.00\n7D\n0%\n1Y\n-8.5%\nGubra\nMarket Cap: US$5.8b\nA biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.\nGUBR.F\nUS$60.15\n7D\n0%\n1Y\nn/a\nEvaxion\nMarket Cap: US$19.2m\nA clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.\nEVAX\nUS$2.86\n7D\n-2.4%\n1Y\n-81.1%\nImmunoPrecise Antibodies\nMarket Cap: US$91.8m\nOperates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company.\nIPA\nUS$2.02\n7D\n9.2%\n1Y\n124.4%\nEvolent Health\nMarket Cap: US$1.0b\nThrough its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.\nEVH\nUS$8.82\n7D\n-9.0%\n1Y\n-67.6%\nGeneDx Holdings\nMarket Cap: US$3.5b\nA genomics company, provides genetic testing services.\nWGS\nUS$122.88\n7D\n16.0%\n1Y\n273.6%\nWELL Health Technologies\nMarket Cap: US$1.3b\nOperates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.\nWHTC.F\nUS$3.45\n7D\n-1.4%\n1Y\n-0.1%\nSpectral AI\nMarket Cap: US$56.5m\nAn artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.\nMDAI\nUS$2.10\n7D\n-12.5%\n1Y\n27.3%\nRevenio Group Oyj\nMarket Cap: US$651.8m\nProvides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.\nREVX.F\nUS$31.47\n7D\n0%\n1Y\nn/a\nRadNet\nMarket Cap: US$5.3b\nProvides outpatient diagnostic imaging services in the United States and internationally.\nRDNT\nUS$68.75\n7D\n30.9%\n1Y\n8.4%\nCareCloud\nMarket Cap: US$107.9m\nA healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.\nCCLD\nUS$2.56\n7D\n3.6%\n1Y\n11.3%\nSimulations Plus\nMarket Cap: US$292.4m\nDevelops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.\nSLP\nUS$14.20\n7D\n1.0%\n1Y\n-61.1%\nPerimeter Medical Imaging AI\nMarket Cap: US$31.0m\nA medical technology company, provides advanced imaging solutions to address unmet medical needs.\nPYNK.F\nUS$0.17\n7D\n-8.4%\n1Y\n-36.9%\nCeriBell\nMarket Cap: US$436.7m\nOperates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.\nCBLL\nUS$11.79\n7D\n-6.3%\n1Y\nn/a\nGuardant Health\nMarket Cap: US$7.3b\nA precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.\nGH\nUS$60.36\n7D\n19.8%\n1Y\n111.5%\nHeartSciences\nMarket Cap: US$8.0m\nA medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.\nHSCS\nUS$3.50\n7D\n-1.1%\n1Y\n6.8%\nNano-X Imaging\nMarket Cap: US$287.7m\nDevelops a commercial-grade tomographic imaging device with a digital X-ray source.\nNNOX\nUS$4.50\n7D\n-2.6%\n1Y\n-38.0%\nOmniAb\nMarket Cap: US$251.5m\nA biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.\nOABI\nUS$2.00\n7D\n6.4%\n1Y\n-52.6%\nNeuroOne Medical Technologies\nMarket Cap: US$42.8m\nA medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.\nNMTC\nUS$0.83\n7D\n9.2%\n1Y\n13.7%\nBioXcel Therapeutics\nMarket Cap: US$69.1m\nTogether with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.\nBTAI\nUS$4.75\n7D\n39.3%\n1Y\n-56.3%\nXtalPi Holdings\nMarket Cap: US$36.7b\nAn investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.\nQNTP.F\nUS$1.07\n7D\n38.4%\n1Y\nn/a\nAbsci\nMarket Cap: US$450.4m\nOperates as a data-first generative artificial intelligence (AI) drug creation company in the United States.\nABSI\nUS$3.00\n7D\n2.7%\n1Y\n-27.5%\nHealwell AI\nMarket Cap: US$400.4m\nA healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom.\nHWAI.F\nUS$1.06\n7D\n3.1%\n1Y\n-27.2%\nVeradigm\nMarket Cap: US$798.2m\nA healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.\nMDRX\nUS$4.60\n7D\n-3.2%\n1Y\n-51.8%\nPersonalis\nMarket Cap: US$428.3m\nDevelops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.\nPSNL\nUS$4.66\n7D\n2.5%\n1Y\n-8.1%"
    },
    {
      "url": "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D?blueprint=3991097&utm_medium=finance_user&utm_campaign=intro&utm_source=yahoo",
      "text": "Hosen Group (5EV) Stock Overview\nAn investment holding company, engages in the development, trading, and distribution of canned seafood products, canned fruits and vegetables, canned meat products, and chocolate products in Singapore, Malaysia, China, and internationally. More details\n| Snowflake Score | |\n|---|---|\n| Valuation | 3/6 |\n| Future Growth | 0/6 |\n| Past Performance | 5/6 |\n| Financial Health | 5/6 |\n| Dividends | 3/6 |\n5EV Community Fair Values\nSee what others think this stock is worth. Follow their fair value or set your own to get alerts.\nHosen Group Ltd. Competitors\nPrice History & Performance\n| Historical stock prices | |\n|---|---|\n| Current Share Price | S$0.05 |\n| 52 Week High | S$0.053 |\n| 52 Week Low | S$0.036 |\n| Beta | 0.0014 |\n| 1 Month Change | 11.11% |\n| 3 Month Change | 4.17% |\n| 1 Year Change | 38.89% |\n| 3 Year Change | -5.66% |\n| 5 Year Change | 47.06% |\n| Change since IPO | -73.68% |\nRecent News & Updates\nRecent updates\nShareholder Returns\n| 5EV | SG Consumer Retailing | SG Market | |\n|---|---|---|---|\n| 7D | 4.2% | 0.5% | 1.0% |\n| 1Y | 38.9% | 33.9% | 27.5% |\nReturn vs Industry: 5EV exceeded the SG Consumer Retailing industry which returned 33.9% over the past year.\nReturn vs Market: 5EV exceeded the SG Market which returned 27.5% over the past year.\nPrice Volatility\n| 5EV volatility | |\n|---|---|\n| 5EV Average Weekly Movement | n/a |\n| Consumer Retailing Industry Average Movement | 4.2% |\n| Market Average Movement | 5.3% |\n| 10% most volatile stocks in SG Market | 16.7% |\n| 10% least volatile stocks in SG Market | 2.5% |\nStable Share Price: Data is not available.\nVolatility Over Time: Insufficient data to determine 5EV's volatility change over the past year.\nAbout the Company\n| Founded | Employees | CEO | Website |\n|---|---|---|---|\n| 1970 | n/a | Daniel Lim | www.hosengroup.com |\nHosen Group Ltd., an investment holding company, engages in the development, trading, and distribution of canned seafood products, canned fruits and vegetables, canned meat products, and chocolate products in Singapore, Malaysia, China, and internationally. It operates through two segments, House Brands and Non-House Brands. The company offers a range of canned food, such as freshly picked and packed fruits and vegetables, condiments, and beverages under the Hosen brand name; canned seafood, such as braised abalone and various types of shellfish under the Fortune brand name; meats and breakfast spreads under the Highway brand; Olive Oil with White Truffle Dressing, Balsamic Vinegar of Modena, Red Grape Vinegar, and White Grape Vinegar under the LaDiva brand; non-alcoholic fizzy beverages under the Royal Select brand; and chocolate products with contents packed in bottle, pouch and tin while Cocoa Grande brand carries semi-finished and finished industrial chocolate products under the Sincero and Calbuco brands.\nHosen Group Ltd. Fundamentals Summary\n| 5EV fundamental statistics | |\n|---|---|\n| Market cap | S$16.25m |\n| Earnings (TTM) | S$2.55m |\n| Revenue (TTM) | S$70.69m |\nIs 5EV overvalued?\nSee Fair Value and valuation analysisEarnings & Revenue\n| 5EV income statement (TTM) | |\n|---|---|\n| Revenue | S$70.69m |\n| Cost of Revenue | S$53.96m |\n| Gross Profit | S$16.73m |\n| Other Expenses | S$14.18m |\n| Earnings | S$2.55m |\nLast Reported Earnings\nJun 30, 2025\nNext Earnings Date\nn/a\n| Earnings per share (EPS) | 0.0078 |\n| Gross Margin | 23.67% |\n| Net Profit Margin | 3.60% |\n| Debt/Equity Ratio | 19.3% |\nHow did 5EV perform over the long term?\nSee historical performance and comparisonDividends\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/14 20:12 |\n| End of Day Share Price | 2025/08/14 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nHosen Group Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D/past?blueprint=3991097&amp;utm_medium=finance_user&amp;utm_campaign=infographic&amp;utm_source=yahoo",
      "text": "Hosen Group Past Earnings Performance\nPast criteria checks 5/6\nHosen Group's earnings have been declining at an average annual rate of -3%, while the Consumer Retailing industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 0.1% per year. Hosen Group's return on equity is 8%, and it has net margins of 3.6%.\nKey information\n-3.00%\nEarnings growth rate\n-3.00%\nEPS growth rate\n| Consumer Retailing Industry Growth | 13.76% |\n| Revenue growth rate | 0.15% |\n| Return on equity | 7.97% |\n| Net Margin | 3.60% |\n| Last Earnings Update | 30 Jun 2025 |\nRecent past performance updates\nRecent updates\nRevenue & Expenses Breakdown\nHow Hosen Group makes and spends money. Based on latest reported earnings, on an LTM basis.\nEarnings and Revenue History\n| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |\n|---|---|---|---|---|\n| 30 Jun 25 | 71 | 3 | 13 | 0 |\n| 31 Mar 25 | 72 | 2 | 13 | 0 |\n| 31 Dec 24 | 73 | 2 | 13 | 0 |\n| 30 Sep 24 | 72 | 2 | 13 | 0 |\n| 30 Jun 24 | 71 | 1 | 12 | 0 |\n| 31 Mar 24 | 69 | 1 | 12 | 0 |\n| 31 Dec 23 | 67 | 1 | 11 | 0 |\n| 30 Sep 23 | 69 | 1 | 11 | 0 |\n| 30 Jun 23 | 71 | 1 | 11 | 0 |\n| 31 Mar 23 | 73 | 1 | 11 | 0 |\n| 31 Dec 22 | 74 | 1 | 11 | 0 |\n| 30 Sep 22 | 71 | 1 | 11 | 0 |\n| 30 Jun 22 | 68 | 2 | 11 | 0 |\n| 31 Mar 22 | 68 | 2 | 11 | 0 |\n| 31 Dec 21 | 68 | 2 | 11 | 0 |\n| 30 Sep 21 | 68 | 3 | 11 | 0 |\n| 30 Jun 21 | 67 | 3 | 10 | 0 |\n| 31 Mar 21 | 69 | 3 | 10 | 0 |\n| 31 Dec 20 | 72 | 3 | 10 | 0 |\n| 30 Sep 20 | 73 | 1 | 11 | 0 |\n| 30 Jun 20 | 74 | 0 | 12 | 0 |\n| 31 Mar 20 | 71 | 0 | 12 | 0 |\n| 31 Dec 19 | 67 | -1 | 11 | 0 |\n| 30 Sep 19 | 67 | 0 | 10 | 0 |\n| 30 Jun 19 | 67 | 1 | 9 | 0 |\n| 31 Mar 19 | 68 | 1 | 10 | 0 |\n| 31 Dec 18 | 68 | 1 | 10 | 0 |\n| 30 Sep 18 | 69 | 1 | 10 | 0 |\n| 30 Jun 18 | 69 | 1 | 10 | 0 |\n| 31 Mar 18 | 68 | 1 | 10 | 0 |\n| 31 Dec 17 | 67 | 1 | 10 | 0 |\n| 30 Sep 17 | 68 | 1 | 10 | 0 |\n| 30 Jun 17 | 68 | 2 | 10 | 0 |\n| 31 Mar 17 | 71 | 1 | 10 | 0 |\n| 31 Dec 16 | 73 | 1 | 10 | 0 |\n| 30 Sep 16 | 74 | 0 | 11 | 0 |\n| 30 Jun 16 | 75 | -1 | 11 | 0 |\n| 31 Mar 16 | 76 | -1 | 11 | 0 |\n| 31 Dec 15 | 76 | -1 | 10 | 0 |\n| 30 Sep 15 | 76 | 0 | 10 | 0 |\n| 30 Jun 15 | 77 | 0 | 10 | 0 |\n| 31 Mar 15 | 75 | 0 | 10 | 0 |\n| 31 Dec 14 | 73 | 1 | 10 | 0 |\n| 30 Sep 14 | 74 | 1 | 10 | 0 |\nQuality Earnings: 5EV has high quality earnings.\nGrowing Profit Margin: 5EV's current net profit margins (3.6%) are higher than last year (1.8%).\nFree Cash Flow vs Earnings Analysis\nPast Earnings Growth Analysis\nEarnings Trend: 5EV has become profitable over the past 5 years, growing earnings by -3% per year.\nAccelerating Growth: 5EV's earnings growth over the past year (101.9%) exceeds its 5-year average (-3% per year).\nEarnings vs Industry: 5EV earnings growth over the past year (101.9%) exceeded the Consumer Retailing industry 4.9%.\nReturn on Equity\nHigh ROE: 5EV's Return on Equity (8%) is considered low.\nReturn on Assets\nReturn on Capital Employed\nDiscover strong past performing companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/14 20:12 |\n| End of Day Share Price | 2025/08/14 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nHosen Group Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/company/id/AE501D0A-B2A5-4748-BBB6-43BF33676D3D/health?blueprint=3991097&utm_medium=finance_user&utm_campaign=integrated-pitch&utm_source=yahoo",
      "text": "Hosen Group Balance Sheet Health\nFinancial Health criteria checks 5/6\nHosen Group has a total shareholder equity of SGD35.9M and total debt of SGD6.9M, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are SGD53.5M and SGD17.5M respectively. Hosen Group's EBIT is SGD2.5M making its interest coverage ratio 7.4. It has cash and short-term investments of SGD6.7M.\nKey information\n19.26%\nDebt to equity ratio\nS$6.92m\nDebt\n| Interest coverage ratio | 7.4x |\n| Cash | S$6.68m |\n| Equity | S$35.92m |\n| Total liabilities | S$17.55m |\n| Total assets | S$53.47m |\nRecent financial health updates\nNo updates\nRecent updates\nFinancial Position Analysis\nShort Term Liabilities: 5EV's short term assets (SGD34.7M) exceed its short term liabilities (SGD13.7M).\nLong Term Liabilities: 5EV's short term assets (SGD34.7M) exceed its long term liabilities (SGD3.9M).\nDebt to Equity History and Analysis\nDebt Level: 5EV's net debt to equity ratio (0.7%) is considered satisfactory.\nReducing Debt: 5EV's debt to equity ratio has reduced from 51.5% to 19.3% over the past 5 years.\nDebt Coverage: 5EV's debt is not well covered by operating cash flow (2.2%).\nInterest Coverage: 5EV's interest payments on its debt are well covered by EBIT (7.4x coverage).\nBalance Sheet\nDiscover healthy companies\nCompany Analysis and Financial Data Status\n| Data | Last Updated (UTC time) |\n|---|---|\n| Company Analysis | 2025/08/14 20:12 |\n| End of Day Share Price | 2025/08/14 00:00 |\n| Earnings | 2025/06/30 |\n| Annual Earnings | 2024/12/31 |\nData Sources\nThe data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.\n| Package | Data | Timeframe | Example US Source * |\n|---|---|---|---|\n| Company Financials | 10 years |\n| |\n| Analyst Consensus Estimates | +3 years |\n|\n|\n| Market Prices | 30 years |\n| |\n| Ownership | 10 years |\n| |\n| Management | 10 years |\n| |\n| Key Developments | 10 years |\n|\n* Example for US securities, for non-US equivalent regulatory forms and sources are used.\nUnless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.\nAnalysis Model and Snowflake\nDetails of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.\nLearn about the world class team who designed and built the Simply Wall St analysis model.\nIndustry and Sector Metrics\nOur industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.\nAnalyst Sources\nHosen Group Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day."
    },
    {
      "url": "https://simplywall.st/discover/investing-ideas/16053/high-return-on-equity-low-debt?blueprint=3991097&utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo",
      "text": "Results\n26\nStocks with a return on equity of over 30% and a debt to equity ratio below 1.\n26 companies\nEvolution\nMarket Cap: SEK 166.6b\nDevelops, produces, markets, and licenses online casino systems to gaming operators in Europe, Asia, North America, Latin America, and internationally.\nEVO\nSEK 823.40\n7D\n-5.9%\n1Y\n-19.7%\nAxfood\nMarket Cap: SEK 65.3b\nEngages in the food retail and wholesale businesses primarily in Sweden.\nAXFO\nSEK 302.20\n7D\n1.1%\n1Y\n10.0%\nAvanza Bank Holding\nMarket Cap: SEK 55.3b\nOffers a range of savings, pension, and mortgages products in Sweden.\nAZA\nSEK 351.50\n7D\n-2.6%\n1Y\n44.5%\nHemnet Group\nMarket Cap: SEK 24.5b\nOperates a residential property platform in Sweden.\nHEM\nSEK 258.80\n7D\n-3.4%\n1Y\n-33.1%\nClas Ohlson\nMarket Cap: SEK 22.0b\nA retail company, sells building, electrical, multimedia, home, and leisure products in Sweden, Norway, Finland, and internationally.\nCLAS B\nSEK 346.00\n7D\n-1.9%\n1Y\n110.7%\nBioArctic\nMarket Cap: SEK 21.1b\nDevelops biological drugs for patients with central nervous system disorders in Sweden.\nBIOA B\nSEK 238.00\n7D\n8.8%\n1Y\n55.4%\nTruecaller\nMarket Cap: SEK 16.3b\nDevelops and publishes mobile caller ID applications for individuals and business in India, the Middle East, Africa, and internationally.\nTRUE B\nSEK 47.38\n7D\n-1.2%\n1Y\n35.4%\nengcon\nMarket Cap: SEK 12.1b\nEngages in the design, production, and sale of excavator tools in Sweden, Denmark, Norway, Finland, rest of Europe, North and South America, Japan, South Korea, Australia, New Zealand, and internationally.\nENGCON B\nSEK 79.40\n7D\n-3.4%\n1Y\n-22.3%\nApotea\nMarket Cap: SEK 11.9b\nOperates an online pharmacy in Sweden.\nAPOTEA\nSEK 114.68\n7D\n-0.8%\n1Y\nn/a\nZinzino\nMarket Cap: SEK 8.9b\nA direct sales company, provides dietary supplements and skincare products in Sweden and internationally.\nZZ B\nSEK 245.00\n7D\n-4.1%\n1Y\n227.5%\nBahnhof\nMarket Cap: SEK 6.4b\nEngages in the Internet and telecommunications business in Sweden and rest of Europe.\nBAHN B\nSEK 59.50\n7D\n-3.3%\n1Y\n17.8%\nIntellego Technologies\nMarket Cap: SEK 4.5b\nManufactures and sells colorimetric ultraviolet indicators in Sweden.\nINT\nSEK 146.80\n7D\n0.5%\n1Y\n424.3%\nLime Technologies\nMarket Cap: SEK 4.4b\nProvides software as a service (SaaS) based customer relationship management (CRM) solutions in the Nordic region.\nLIME\nSEK 329.50\n7D\n-11.8%\n1Y\n-2.7%\nNelly Group\nMarket Cap: SEK 2.5b\nOperates as a fashion company in Sweden, rest of Nordics, and internationally.\nNELLY\nSEK 82.40\n7D\n10.8%\n1Y\n210.9%\nSolid F\u00f6rs\u00e4kringsaktiebolag\nMarket Cap: SEK 1.3b\nProvides non-life insurance to private and business customers in Sweden, Denmark, Norway, Finland, and internationally.\nSFAB\nSEK 74.30\n7D\n0.8%\n1Y\n-15.3%\nSoftronic\nMarket Cap: SEK 1.2b\nProvides IT and management services in Sweden.\nSOF B\nSEK 23.60\n7D\n0%\n1Y\n4.9%\nNovotek\nMarket Cap: SEK 1.1b\nNovotek AB delivers solutions in the industrial IT and automation areas in Sweden, Norway, Denmark, Finland, Benelux countries, the United Kingdom, Ireland, and Switzerland.\nNTEK B\nSEK 104.50\n7D\n1.5%\n1Y\n43.5%\nMicro Systemation\nMarket Cap: SEK 1.0b\nProvides forensic technology for mobile device examination and analysis in Sweden and internationally.\nMSAB B\nSEK 56.00\n7D\n-2.1%\n1Y\n29.9%\nSinterCast\nMarket Cap: SEK 799.3m\nProvides process control technology to produce compacted graphite iron (CGI) for the foundry and automotive industries in Brazil, Mexico, Sweden, the United States of America, Korea, China, Spain, Japan, the United Kingdom, and internationally.\nSINT\nSEK 113.50\n7D\n-1.3%\n1Y\n-2.6%\nOpter\nMarket Cap: SEK 729.0m\nA SaaS company, provides transport planning solutions primarily in Sweden, Norway, Finland, Denmark, and other Nordic countries.\nOPTER\nSEK 121.50\n7D\n-2.8%\n1Y\n24.0%\nGeneric Sweden\nMarket Cap: SEK 658.9m\nA technology company, provides messaging services for all applications.\nGENI\nSEK 53.60\n7D\n0.6%\n1Y\n16.5%\nHomeMaid\nMarket Cap: SEK 644.4m\nProvides cleaning services in Sweden.\nHOME B\nSEK 34.00\n7D\n0%\n1Y\n120.8%\nSibek\nMarket Cap: SEK 466.0m\nEngages in the investigation, planning, project designing and safety reviewing, inspection, and commissioning management of railway signaling systems in Sweden.\nSIBEK\nSEK 45.90\n7D\n4.1%\n1Y\n38.7%\nFable Media Group\nMarket Cap: SEK 163.1m\nInvests in marketing businesses.\nFABLE\nSEK 4.80\n7D\n-7.3%\n1Y\n-37.3%\nComintelli\nMarket Cap: SEK 33.2m\nA software company, provides software as a service solution for external monitoring and analysis.\nCOMINT\nSEK 3.30\n7D\n-4.1%\n1Y\n22.2%\nTransiro Holding\nMarket Cap: SEK 30.5m\nDevelops systems for trade and transport industry in Sweden.\nTIRO\nSEK 0.04\n7D\n0%\n1Y\n21.2%"
    }
  ],
  "argos_summary": "Hosen Group Ltd. recently reported solid earnings, but concerns arise from a significant portion of profit stemming from unusual items, which may not be sustainable. The company's statutory earnings may not accurately reflect its ongoing productivity, and while its EPS growth has been impressive, investors should be cautious due to identified risks. Hosen Group operates in the canned food sector and has shown mixed performance in revenue growth compared to the industry.",
  "argos_id": "3Z1768UL2"
}